[Elsevier] Management of cutaneous toxicities under amivantamab (anti MET and anti EGFR bispecific antibody) in patients with metastatic non-small cell lung cancer harboring EGFR Exon20ins: towards a proactive, multidisciplinary approach

icarus Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-07-28 00:10
Reward10points

journalㄩLung Cancer

AuthorsㄩCl谷mence Basse; H谷di Chabanol; Pierre-Emmanuel Bonte; Isabelle Fromantin; Nicolas Girard

Published dateㄩ2022-11-

DOIㄩ10.1016/j.lungcan.2022.09.012

PDF linkㄩhttps://www.sciencedirect.com/sc ... 169500222006419/pdf

Article linkㄩhttps://doi.org/10.1016/j.lungcan.2022.09.012

Article SourceㄩElsevier BV


Remarkㄩ

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
jakir_ete_ruet Post time 1 hour(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Senior Member
  • post

  • reply

  • points

    1470


Return to the list